Riskpilot← Back to searchSign inGet full accessElite Test Stockholm AB
ABBankruptOrg 5592574577StockholmGeneral medical practice activities · NACE 8621Est. 20200 employees
Revenue 2021
SEK 3,7M
EBITDA margin
19.7%
+73300% vs 2020
Equity ratio
14.9%
Financial strength
Net profit 2021
SEK 409K
+41000% vs 2020
| Revenue | SEK 3,7M | — |
| EBITDA | SEK 732K | +73300% |
| Net profit | SEK 409K | +41000% |
| Total assets | SEK 2,9M | +12067% |
| Equity | SEK 434K | +1708% |
| Employees | 0 | — |
Legal name
Elite Test Stockholm AB
Org number
5592574577
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
28 maj 2020
Share capital
SEK 25 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas ensam av likvidatorn
Company purpose
Bolaget kommer att bedriva vårdtjänster riktat till både privatpersoner och företag såsom virustestning och utfärdande av reseintyg.
Address
Stockholm
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 |
|---|---|---|
| Revenue | 0 | 3 719 |
| Staff expenses | — | — |
| EBITDA | −1 | 732 |
| Depreciation & amort. | −0 | −28 |
| EBIT | −1 | 704 |
| Net financials | — | −2 |
| Profit before tax | −1 | 521 |
| Tax | −0 | −112 |
| Net profit | −1 | 409 |
| Item | 2020 | 2021 |
|---|---|---|
| Total assets | 24 | 2 920 |
| Equity | 24 | 434 |
| Long-term debt | 0 | 266 |
| Short-term debt | 0 | 2 040 |
| Total debt | — | 2 306 |
EBITDA margin
19.7%
This company
15.8%
Market median
+25% vs market
20202021
Equity ratio
14.9%
This company
38.2%
Market median
-61% vs market
20202021
Return on equity
94.2%
This company
18.4%
Market median
+412% vs market
20202021
Net profit margin
11.0%
This company
8.1%
Market median
+36% vs market
20202021
Asset turnover
1.27×
This company
1.12×
Market median
+13% vs market
20202021
Debt / equity
5.73×
This company
0.62×
Market median
-824% vs market
20202021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-05-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CC Liquidator | Liquidator | 2024 |
| Name | Role | Member since |
|---|---|---|
| Former (6) | ||
| Deputy Board Member | 2021 – 2022 | |
| Board of Directors | 2022 – 2023 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2022 – 2024 | |
| Deputy Board Member | 2022 – 2023 | |
| Deputy Board Member | 2022 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Elite Test Stockholm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Carl Christofer Daniel Hemsedahl | Liquidator | 0 companies |
| Adel Amin Belalia | Deputy Board Member | 0 companies |
| Elias Belalia | Board of Directors | 0 companies |
| Adam Belalia | Board of Directors | 0 companies |
| Vilgot Leo Erik Falk | Board of Directors | 0 companies |
| Melanie Sofie Nikolic | Deputy Board Member | 0 companies |
| Jaber Abdullah Abdulqader | Deputy Board Member | 0 companies |